valproic acid has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Borowicz, KK; Czuczwar, SJ; Gasior, M; Kleinrok, Z | 1 |
Brown-Croyts, LM; Ko, GY; Teyler, TJ | 1 |
Deckert, J; Gsell, W; Künig, G; Niedermeyer, B; Ransmayr, G; Riederer, P | 1 |
Desai, NS; Higgins, EA; Walcott, EC | 1 |
Franke, H; Illes, P; Khan, MT; Liu, J; Nerlich, J; Tang, Y | 1 |
Bhatia, A; Joshi, R; Kaur, G; Kumar, R; Medhi, B; Mishra, A; Prajapat, M; Sarma, P; Sharma, A; Singla, R | 1 |
Knake, S; Kovac, S; Rosenow, F; Strzelczyk, A; van der Goten, M; von Podewils, F; Willems, LM; Zöllner, JP | 1 |
Abdelhakam, DA; Aboul-Ela, YM; Aboul-Fotouh, S; Ebeid, MA; Elnahas, EM; Habib, MZ; Negm, EA; Sadek, DR; Tarek, M | 1 |
8 other study(ies) available for valproic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Article | Year |
---|---|
The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Electroshock; Female; Mice; Mice, Inbred Strains; Motor Activity; Rats; Valproic Acid | 1995 |
The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Electrophysiology; gamma-Aminobutyric Acid; Hippocampus; Male; N-Methylaspartate; Phenobarbital; Phenytoin; Rats; Rats, Inbred Strains; Valproic Acid | 1997 |
Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: an autoradiographic investigation in human hippocampus.
Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anticonvulsants; Autoradiography; Drug Interactions; Excitatory Amino Acid Agonists; Hippocampus; Humans; Valproic Acid | 1998 |
Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero.
Topics: Abnormalities, Drug-Induced; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Female; Male; Models, Neurological; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Pregnancy; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Synaptic Potentials; Time Factors; Valproic Acid | 2011 |
Regulation of P2X7 receptor function of neural progenitor cells in the hippocampal subgranular zone by neuronal activity in the dentate gyrus.
Topics: 4-Aminopyridine; Action Potentials; Adenosine Triphosphate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cells, Cultured; Dentate Gyrus; Female; Gabapentin; Male; Mice; Muscimol; N-Methylaspartate; Neural Stem Cells; Neurons; Phenytoin; Receptors, Purinergic P2X7; Tetrodotoxin; Valproic Acid | 2018 |
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spectrum Disorder; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Granulocyte Colony-Stimulating Factor; Hippocampus; Humans; N-Methylaspartate; Neuroprotective Agents; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, AMPA; Receptors, Glutamate; Risperidone; Saline Solution; Valproic Acid | 2022 |
Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy.
Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Retrospective Studies; Topiramate; Valproic Acid; Zonisamide | 2023 |
Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Topics: Adenosine Deaminase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spectrum Disorder; Autistic Disorder; Disease Models, Animal; Female; Glutamic Acid; Pregnancy; Rats; Receptors, AMPA; Risperidone; RNA; RNA Editing; Valproic Acid | 2023 |